Recent investigations on retatrutides, a dual agonist for GLP-1 and gastric inhibitory polypeptide, demonstrate significant findings in managing weight gain and type 2 diabetic condition. Early evidence from clinical assessments show notable diminutions in body bulk and improved glucose regulation. Ongoing examination is centered on long-term ha… Read More